Seagate's strong Q1 results and HAMR drive ramp drive growth, with cloud-focused high-capacity production under contract through 2026.
Meta posts record Q3 revenue, but faces mounting legal and regulatory risks as it invests heavily in AI and hardware.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
Seagate's strong Q1 results and HAMR drive ramp drive growth, with cloud-focused high-capacity production under contract through 2026.
Meta posts record Q3 revenue, but faces mounting legal and regulatory risks as it invests heavily in AI and hardware.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.